{
  "abstract": null,
  "abstract_shown": false,
  "affiliations": [
    "Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation Children's Mercy Hospital Kansas City Missouri USA",
    "Division of Pediatric Neurology Children's Mercy Hospital Kansas City Missouri USA",
    "Department of Pediatrics University of Missouri‐Kansas City School of Medicine Kansas City Missouri USA",
    "Frontiers Clinical and Translational Science Institute and the University of Kansas University of Kansas Medical Center Kansas City Kansas USA",
    "Ward Family Heart Center Children's Mercy Kansas City Missouri USA"
  ],
  "article_type": "other",
  "arxiv": null,
  "author_total": 3,
  "authors": [
    {
      "affs": [
        0,
        1,
        2
      ],
      "name": "Rose Gelineau‐Morel",
      "orcid": "0000-0002-7387-9082"
    },
    {
      "affs": [
        0,
        2,
        3
      ],
      "name": "J. Steven Leeder",
      "orcid": "0000-0001-6688-0504"
    },
    {
      "affs": [
        0,
        2,
        4
      ],
      "name": "Jonathan B. Wagner",
      "orcid": "0000-0001-7690-6798"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/705xtj79n67n5.bib",
  "cited_by": 0,
  "doi": "10.1002/cpt.70532",
  "fulltext_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC13698882/",
  "id": "705xtj79n67n5",
  "issns": [
    "0009-9236",
    "1532-6535"
  ],
  "landing_url": "https://doi.org/10.1002/cpt.70532",
  "language": "en",
  "licence": "unknown",
  "licence_label": "Licence not stated",
  "licence_source": "unknown",
  "licence_url": null,
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "Perspective"
    ],
    [
      "heading",
      "Understudied Populations"
    ],
    [
      "openalex",
      "2735|Pharmaceutical studies and practices"
    ]
  ],
  "openalex": "W7223707507",
  "pdf_url": null,
  "pmcid": "PMC13698882",
  "pmid": "42929250",
  "published": "2026-10-26",
  "publisher": null,
  "ris": "https://research.draconitic.com/paper/705xtj79n67n5.ris",
  "sources": [
    {
      "first_seen": "2026-10-30T12:19:35Z",
      "native_id": "PMC13698882",
      "source": "pmc",
      "url": "https://doi.org/10.1002/cpt.70532"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2735|Pharmaceutical studies and practices",
      "subfield": "reproductive-child"
    }
  ],
  "title": "Advancing Therapeutics for Children with Medical Complexity: The Role of Model‐Informed Precision Dosing and Genotype‐Stratified Trials",
  "title_text": "Advancing Therapeutics for Children with Medical Complexity: The Role of Model‐Informed Precision Dosing and Genotype‐Stratified Trials",
  "type": "peer-reviewed",
  "updated_at": "2026-10-30T12:35:32Z",
  "url": "https://research.draconitic.com/paper/705xtj79n67n5",
  "venue": "Clinical Pharmacology and Therapeutics",
  "versions": []
}